End Tidal CO2 and Masks: Is There a Correlation?
Launched by CHRISTUS HEALTH · May 24, 2024
Trial Information
Current as of March 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy individuals between the ages of 18 and 75
- • Consent to participate in this study
- • Resident and ancillary staff
- Exclusion Criteria:
- • Patients
- • Inability or refusal consent
- • Inability to walk the predetermined distance
- • History of lung disease
- • History of significant cardiac disease
- • People under the age of 18 and over the age of 75
About Christus Health
Christus Health is a leading global healthcare organization dedicated to providing high-quality, compassionate care across a diverse range of medical specialties. With a strong commitment to innovation and research, Christus Health actively sponsors clinical trials aimed at advancing medical knowledge and improving patient outcomes. By fostering collaborations with researchers and healthcare professionals, the organization seeks to explore new treatments and therapies that address critical health challenges. With a focus on ethical practices and patient safety, Christus Health is dedicated to enhancing the well-being of the communities it serves through evidence-based research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Corpus Christi, Texas, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
